Solid Tumor Show to Express DLL3 trials recruiting in Pennsylvania

Fewer than 3 recruiting trials found.

All Solid Tumor Show to Express DLL3 trials nationally

Cities in Pennsylvania

Recruiting trials in Pennsylvania

• A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
  NCT07174583 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia